Compare Morgan Stanley (MS) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Morgan Stanley vs 22nd Century Group Inc — how do they compare? Morgan Stanley trades at $215.3 (market cap $338.09B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Morgan Stanley is far larger — about 222427.6× 22nd Century Group Inc's market cap, and Morgan Stanley pays a 2.14% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| MS | XXII | |
|---|---|---|
Market Cap | $338.09B | $1.52M |
Sector | Financials | Technology |
52-Week High | $228.42 | $801.00 |
52-Week Low | $144.04 | $3.72 |
Dividend Yield | 2.14% | — |
Enterprise Value | — | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $215.27, down 0.46% on the day, with a neutral technical signal. The stock shows strong fundamentals, with revenue growing from $50.2B in 2022 to $66.0B in 2025 and net income margin expanding to 27.59%. Recent earnings beats and the selection to lead the Anthropic IPO highlight operational strength. The consensus analyst price target is $239.58, implying potential upside.
The outlook is positive, supported by earnings momentum and strategic initiatives like AI integration in wealth management. Key risks include volatile cash flows from operations and high leverage, with debt-to-asset ratio rising to 26.1 in 2025. Analyst sentiment is bullish, with 55.77% recommending Buy.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
